BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 36480479)

  • 41. Cardiac events following JYNNEOS vaccination for prevention of Mpox.
    Sharff KA; Tandy TK; Lewis PF; Johnson ES
    Vaccine; 2023 May; 41(22):3410-3412. PubMed ID: 37117055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Asymptomatic and Subclinical Mpox: An Association With Modified Vaccinia Ankara Vaccine.
    Golden MR; Soge OO; Mills M; Berzkalns A; Cannon C; Ramchandani M; Dombrowski JC; Karmarkar EN; Chow EJ; Gov JP; Swenson P; Greninger AL
    Sex Transm Dis; 2024 May; 51(5):342-347. PubMed ID: 38301634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A survey-based assessment of rates and covariates of mpox diagnosis and vaccination provides evidence to refine eligibility criteria for mpox vaccination among gay, bisexual and other men who have sex with men in the Netherlands.
    Adam PCG; Op de Coul ELM; Zantkuijl P; Xiridou M; Bos H; Blom C; Ketsuwan I; Te Wierik MJM; David S; de Wit JBF
    Front Public Health; 2024; 12():1194844. PubMed ID: 38351958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of an mpox outbreak affecting many vaccinated persons in Chicago, IL-March 2023-June 2023.
    Faherty EAG; Holly T; Ogale YP; Spencer H; Becht AM; Crisler G; Wasz M; Stonehouse P; Barbian HJ; Zelinski C; Kittner A; Foulkes D; Anderson KW; Evans T; Nicolae L; Staton A; Hardnett C; Townsend MB; Carson WC; Panayampalli SS; Hutson CL; Gigante CM; Quilter LAS; Gorman S; Borah B; Black SR; Pacilli M; Kern D; Kerins J; McCollum AM; Rao AK; Tabidze I
    Clin Infect Dis; 2024 Apr; ():. PubMed ID: 38567460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mpox: Rapid Evidence Review.
    Saguil A; Krebs L; Choe U
    Am Fam Physician; 2023 Jul; 108(1):78-83. PubMed ID: 37440743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An early pop-up mpox vaccine clinic.
    Hicks RW; Blackwell C
    J Am Assoc Nurse Pract; 2023 Apr; 35(4):226-228. PubMed ID: 37017503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential for Recurrent Mpox Outbreaks Among Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2023.
    Pollock ED; Clay PA; Keen A; Currie DW; Carter RJ; Quilter LAS; Gundlapalli AV; Mermin J; Spicknall IH
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(21):568-573. PubMed ID: 37227964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What determines mpox vaccination uptake? Assessing the effect of intent-to-vaccinate versus other determinants among men who have sex with men.
    Jongen VW; Groot Bruinderink ML; Boyd A; Koole JCD; Teker B; Dukers-Muijrers NHTM; Evers YJ; Schim van der Loeff MF; Prins M; de Vries HJC; Matser A; Davidovich U
    Vaccine; 2024 Jan; 42(2):186-193. PubMed ID: 38072753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Demographics and Health Beliefs of Black Gay, Bisexual, and Other Sexual Minority Men Receiving a Mpox Vaccination in the United States.
    Ogunbajo A; Euceda A; Smith J; Ekundayo R; Wattree J; Brooks M; Hickson D
    J Urban Health; 2023 Feb; 100(1):204-211. PubMed ID: 36662397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
    Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influences of mpox disease perceptions, sources and contents of information exposure on mpox vaccine uptake among gay, bisexual, and other men who have sex with men in Hong Kong, China.
    Cheung DH; Chen S; Fang Y; Sun F; Zhang Q; Yu FY; Mo PKH; Wang Z
    Vaccine; 2024 Apr; 42(9):2337-2346. PubMed ID: 38480102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington.
    Ramchandani MS; Berzkalns A; Cannon CA; Dombrowski JC; Brown E; Chow EJ; Barash E; Pogosjans S; Smith D; Golden MR
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad528. PubMed ID: 37942460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mpox Cases Among Cisgender Women and Pregnant Persons - United States, May 11-November 7, 2022.
    Oakley LP; Hufstetler K; O'Shea J; Sharpe JD; McArdle C; Neelam V; Roth NM; Olsen EO; Wolf M; Pao LZ; Gold JAW; Davis KM; Perella D; Epstein S; Lash MK; Samson O; Pavlick J; Feldpausch A; Wallace J; Nambiar A; Ngo V; Halai UA; Richardson CW; Fowler T; Taylor BP; Chou J; Brandon L; Devasia R; Ricketts EK; Stockdale C; Roskosky M; Ostadkar R; Vang Y; Galang RR; Perkins K; Taylor M; Choi MJ; Weidle PJ; Dawson P; Ellington S;
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(1):9-14. PubMed ID: 36602932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.
    Johnson AG; Amin AB; Ali AR; Hoots B; Cadwell BL; Arora S; Avoundjian T; Awofeso AO; Barnes J; Bayoumi NS; Busen K; Chang C; Cima M; Crockett M; Cronquist A; Davidson S; Davis E; Delgadillo J; Dorabawila V; Drenzek C; Eisenstein L; Fast HE; Gent A; Hand J; Hoefer D; Holtzman C; Jara A; Jones A; Kamal-Ahmed I; Kangas S; Kanishka F; Kaur R; Khan S; King J; Kirkendall S; Klioueva A; Kocharian A; Kwon FY; Logan J; Lyons BC; Lyons S; May A; McCormick D; ; Mendoza E; Milroy L; O'Donnell A; Pike M; Pogosjans S; Saupe A; Sell J; Smith E; Sosin DM; Stanislawski E; Steele MK; Stephenson M; Stout A; Strand K; Tilakaratne BP; Turner K; Vest H; Warner S; Wiedeman C; Zaldivar A; Silk BJ; Scobie HM
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):132-138. PubMed ID: 35085223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response.
    Ladhani SN; Dowell AC; Jones S; Hicks B; Rowe C; Begum J; Wailblinger D; Wright J; Owens S; Pickering A; Shilltoe B; McMaster P; Whittaker E; Zuo J; Powell A; Amirthalingam G; Mandal S; Lopez-Bernal J; Ramsay ME; Kissane N; Bell M; Watson H; Ho D; Hallis B; Otter A; Moss P; Cohen J
    Lancet Infect Dis; 2023 Sep; 23(9):1042-1050. PubMed ID: 37336224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characteristics of mpox infection in individuals who received a first dose of modified vaccinia Ankara immunisation.
    Agunbiade S; Burton F; Muirhead J; Whitlock GG; Girometti N
    Sex Transm Infect; 2023 May; 99(3):198-199. PubMed ID: 36596674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.
    Jacob-Dolan C; Ty D; Hope D; McMahan K; Liu J; Powers OC; Cotter CA; Sciacca M; Wu C; Borducchi E; Bouffard E; Richter H; Velasco J; Teow E; Boursiquot M; Cook A; Feliciano K; Yalley-Ogunro J; Seaman MS; Pessiant L; Lewis MG; Andersen H; Moss B; Barouch DH
    Sci Transl Med; 2024 Mar; 16(740):eadl4317. PubMed ID: 38536937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May-July 2022.
    van Ewijk CE; Smit C; Bavalia R; Ainslie K; Vollaard A; van Rijckevorsel G; Hahné SJM
    Vaccine; 2023 Nov; 41(47):6952-6959. PubMed ID: 37838481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.).
    Griffin I; Berry I; Navarra T; Priyamvada L; Carson WC; Noiman A; Jackson DA; Waltenburg MA; Still W; Lujan L; Beverly J; Willut C; Lee M; Mangla A; Shelus V; Hutson CL; Townsend MB; Satheshkumar PS;
    Vaccine; 2024 May; ():. PubMed ID: 38762357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.